John Allen Farlinger, CEO and Director, acquired 16,200 Common Shares on a direct ownership basis at a price of $6.190USD through a private transaction on November 29th, 2021. This represents a $128,005 investment into the company's shares and an account share holdings change of 12.1%.
John Price, CFO, acquired 13,700 Common Shares on a direct ownership basis at a price of $6.190USD through a private transaction on November 29th, 2021. This represents a $108,251 investment into the company's shares and an account share holdings change of greater than 100%.
Preston Parsons, a Senior Officer, Director and 10% Holder, acquired 8,100 Common Shares on a direct ownership basis at a price of $6.190USD through a private transaction on November 29th, 2021. This represents a $64,002 investment into the company's shares and an account share holdings change of 0.7%.
Alex Rasmussen, a Senior Officer, acquired 8,100 Common Shares on a direct ownership basis at a price of $6.190USD through a private transaction on November 29th, 2021. This represents a $64,002 investment into the company's shares and an account share holdings change of 12.2%.
John Flood, a Director, acquired 3,000 Common Shares on a direct ownership basis at a price of $6.190USD through a private transaction on November 29th, 2021. This represents a $23,705 investment into the company's shares and an account share holdings change of 7.5%.
Christopher Rumana, a Director, acquired 3,000 Common Shares on a direct ownership basis at a price of $6.190USD through a private transaction on November 29th, 2021. This represents a $23,705 investment into the company's shares and an account share holdings change of 10.8%.
Steven Summer, a Director, acquired 3,000 Common Shares on a direct ownership basis at a price of $6.190USD through a private transaction on November 29th, 2021. This represents a $23,705 investment into the company's shares and an account share holdings change of 38.4%.
Scott Kozak, a Senior Officer, acquired 1,700 Common Shares on a direct ownership basis at a price of $6.190USD through a private transaction on November 29th, 2021. This represents a $13,433 investment into the company's shares and an account share holdings change of 34.0%.
Assure Holdings is in the Healthcare Facilities & Services Sub Industry Group under the Healthcare Sector.
Assure Holdings Corp. provides intraoperative neuromonitoring (IONM) surgical support services primarily associated with spine and head surgeries. The Company primarily engages in the neuromonitoring of neurosurgeries, spinal procedures and vascular surgeries. It applies its neuromonitoring platform to additional surgical verticals such as ear nose and throat, orthopedic and others. It provides IONM services from scheduling of the intraoperative neurophysiologic (INP) and supervising practitioner, real time monitoring and subsequent billing for the services. The Company provides IONM services for approximately 131 surgeons in 66 hospitals and surgery centers, located in Colorado, Texas, Louisiana, Pennsylvania, Michigan, South Carolina and Arizona. The Company operates through its two indirect subsidiaries: Assure Neuromonitoring, LLC (Neuromonitoring) and Assure Networks, LLC (Networks).
No Comments